BackAcceleron Pharma Overview

Acceleron Pharma Total Revenue

Revenue analysis for XLRN.

Quarterly Revenue

$34.20M
↑ 51.58% YoY

As of Sep 2021

Annual Revenue (TTM)

$112.76M
↑ 6.38% YoY

Trailing 12 months ending Sep 2021

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin